CAS: 19948-85-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-[5-(4-Methylphenyl)-1,3,4-thiadiazol-2-yl]benzamide REF: IN-DA024H31CAS: 19948-85-7 | 95% | To inquire | Mon 14 Apr 25 |
 | FAK-IN-7 REF: 54-BUP05886CAS: 19948-85-7 | - - - | 260.00 €~813.00 € | Tue 15 Apr 25 |
 | FAK-IN-7 REF: TM-T9973CAS: 19948-85-7 | 98.2% | 35.00 €~1,336.00 € | Tue 15 Apr 25 |
N-[5-(4-Methylphenyl)-1,3,4-thiadiazol-2-yl]benzamide
CAS:19948-85-7
Formula:
C16H13N3OS
Purity:
95%
Color and Shape:
Solid
Molecular weight:
295.3589
Ref: IN-DA024H31
| 5mg | 194.00 € | ||
| 10mg | 236.00 € | ||
| 25mg | 623.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 14 Apr 2025
Ref: 54-BUP05886
| 25mg | 260.00 € | ||
| 50mg | 394.00 € | ||
| 100mg | 571.00 € | ||
| 200mg | 813.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
FAK-IN-7
CAS:19948-85-7
FAK-IN-7 has potential antiproliferative activity and is a FAK inhibitor.
Formula:
C16H13N3OS
Purity:
98.2%
Color and Shape:
Liquid
Molecular weight:
295.36
Ref: TM-T9973
| 2mg | 35.00 € | ||
| 5mg | 50.00 € | ||
| 10mg | 88.00 € | ||
| 25mg | 167.00 € | ||
| 50mg | 259.00 € | ||
| 100mg | 383.00 € | ||
| 200mg | 545.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
